Skip to content

Efficacy Influencing Factors of Platelet-rich Plasma in the Treatment of Knee Osteoarthritis: A Clinical Retrospective Study

Efficacy Influencing Factors of Platelet-rich Plasma in the Treatment of Knee Osteoarthritis: A Clinical Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500103500
Enrollment
Unknown
Registered
2025-05-30
Start date
2025-05-30
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

Observation group:None

Sponsors

Rehabilitation Medicine Center, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Main Inclusion Criteria: Diagnosed with knee osteoarthritis (KOA) according to the 2021 edition of the Chinese Guidelines for the Diagnosis and Treatment of Knee Osteoarthritis. The specific requirements are: recurrent knee pain in the past 1 month and at least 2 of the following: (1) Imaging findings: Standing or weight-bearing X-ray examination shows narrowing of the joint space, subchondral osteosclerosis and/or cystic changes, and osteophyte formation at the joint margin. (2) Age: Age>=50 years. (3) Morning stiffness: Morning stiffness duration =40/100; (2) Have received at least 1 platelet-rich plasma (PRP) injection.

Exclusion criteria

Exclusion criteria: 1. Combined with one or more lower limb non-knee joint problems that affect daily activities; 2. Treatment with intra-articular steroids or biologic injections such as PRP within 8 weeks; 3. Received other treatment regimens that may have an impact on the observation indicators of PRP treatment within the past year, such as biological therapy such as stem cells, systemic immunosuppressive drugs, etc.

Design outcomes

Primary

MeasureTime frame
the Visual Analog Scale ;the Western Ontario and McMaster Universities Osteoarthritis Index;

Secondary

MeasureTime frame
Safety;Continuous remission rate and cause of symptom induction;

Countries

China

Contacts

Public ContactHongchen He

Rehabilitation Medicine Center, West China Hospital, Sichuan University

hxkfhhc@126.com+86 189 8060 2262

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026